L'outcome del neonato affetto da ernia diaframmatica congenita. (The outcome of the newborn infant suffering from congenital diaphragmatic hernia).

Research output: Contribution to journalArticle

Abstract

Congenital diaphragmatic hernia (CDH) is one of the most serious and controversial congenital anomalies. Pulmonary hypoplasia with/without pulmonary hypertension (and major associated anomalies) are reported the main causes of death in these patients. New treatment strategies for CDH have allowed an increase of survival also of more severe patients. As a consequence many attentions are now focused on long term follow up of these delicate babies. Many reports, in the last years, have highlighted associated morbidities in CDH survivors, such as pulmonary sequelae, neurodevelopmental delay, auxological deficits, gastrointestinal and orthopedic disorders. Therefore it is nowadays quite evident that this group of patient is a complex population to care during the first year of life but also throughout infancy and childhood, thus requiring a well defined follow up. Single institution data on overall survival have been frequently reported, only few of these however reported long term follow up of their patients. The aim of this short review is to describe the mid and long term outcomes of CDH survivors, suggesting also a personal view of follow up protocol for these babies.

Original languageEnglish
Pages (from-to)95-97
Number of pages3
JournalMinerva Pediatrica
Volume62
Issue number3 Suppl 1
Publication statusPublished - Jun 2010

Fingerprint

Newborn Infant
Survivors
Musculoskeletal Diseases
Lung
Survival
Pulmonary Hypertension
Cause of Death
Morbidity
Congenital Diaphragmatic Hernias
Population
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{e9c33b57fbf940c2b597189274333001,
title = "L'outcome del neonato affetto da ernia diaframmatica congenita. (The outcome of the newborn infant suffering from congenital diaphragmatic hernia).",
abstract = "Congenital diaphragmatic hernia (CDH) is one of the most serious and controversial congenital anomalies. Pulmonary hypoplasia with/without pulmonary hypertension (and major associated anomalies) are reported the main causes of death in these patients. New treatment strategies for CDH have allowed an increase of survival also of more severe patients. As a consequence many attentions are now focused on long term follow up of these delicate babies. Many reports, in the last years, have highlighted associated morbidities in CDH survivors, such as pulmonary sequelae, neurodevelopmental delay, auxological deficits, gastrointestinal and orthopedic disorders. Therefore it is nowadays quite evident that this group of patient is a complex population to care during the first year of life but also throughout infancy and childhood, thus requiring a well defined follow up. Single institution data on overall survival have been frequently reported, only few of these however reported long term follow up of their patients. The aim of this short review is to describe the mid and long term outcomes of CDH survivors, suggesting also a personal view of follow up protocol for these babies.",
author = "P. Bagolan",
year = "2010",
month = "6",
language = "English",
volume = "62",
pages = "95--97",
journal = "Minerva Pediatrica",
issn = "0026-4946",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3 Suppl 1",

}

TY - JOUR

T1 - L'outcome del neonato affetto da ernia diaframmatica congenita. (The outcome of the newborn infant suffering from congenital diaphragmatic hernia).

AU - Bagolan, P.

PY - 2010/6

Y1 - 2010/6

N2 - Congenital diaphragmatic hernia (CDH) is one of the most serious and controversial congenital anomalies. Pulmonary hypoplasia with/without pulmonary hypertension (and major associated anomalies) are reported the main causes of death in these patients. New treatment strategies for CDH have allowed an increase of survival also of more severe patients. As a consequence many attentions are now focused on long term follow up of these delicate babies. Many reports, in the last years, have highlighted associated morbidities in CDH survivors, such as pulmonary sequelae, neurodevelopmental delay, auxological deficits, gastrointestinal and orthopedic disorders. Therefore it is nowadays quite evident that this group of patient is a complex population to care during the first year of life but also throughout infancy and childhood, thus requiring a well defined follow up. Single institution data on overall survival have been frequently reported, only few of these however reported long term follow up of their patients. The aim of this short review is to describe the mid and long term outcomes of CDH survivors, suggesting also a personal view of follow up protocol for these babies.

AB - Congenital diaphragmatic hernia (CDH) is one of the most serious and controversial congenital anomalies. Pulmonary hypoplasia with/without pulmonary hypertension (and major associated anomalies) are reported the main causes of death in these patients. New treatment strategies for CDH have allowed an increase of survival also of more severe patients. As a consequence many attentions are now focused on long term follow up of these delicate babies. Many reports, in the last years, have highlighted associated morbidities in CDH survivors, such as pulmonary sequelae, neurodevelopmental delay, auxological deficits, gastrointestinal and orthopedic disorders. Therefore it is nowadays quite evident that this group of patient is a complex population to care during the first year of life but also throughout infancy and childhood, thus requiring a well defined follow up. Single institution data on overall survival have been frequently reported, only few of these however reported long term follow up of their patients. The aim of this short review is to describe the mid and long term outcomes of CDH survivors, suggesting also a personal view of follow up protocol for these babies.

UR - http://www.scopus.com/inward/record.url?scp=79952111174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952111174&partnerID=8YFLogxK

M3 - Article

C2 - 21089726

AN - SCOPUS:79952111174

VL - 62

SP - 95

EP - 97

JO - Minerva Pediatrica

JF - Minerva Pediatrica

SN - 0026-4946

IS - 3 Suppl 1

ER -